Winton Group’s Medline Inc MDLN Stock Holding History

Winton Group’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.5M	Buy	367,057 +340,127	+1,263%	+$13.7M	0.47%	40
2026 Q1	$1.2M	Buy	+26,930	New	+$1.19M	0.04%	492

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winton Group's MDLN Position: Q2 2026 in Review

Winton Group increased its Medline Inc (MDLN) stake by 1,263% in Q2 2026, buying an estimated $13.7M and bringing the position to 367,057 shares worth $14.5M. The position accounts for 0.47% of the portfolio, ranked #40.

Winton Group first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Winton Group held 367,057 shares of Medline Inc worth $14.5M as of Q2 2026.
Winton Group bought 340,127 Medline Inc shares in Q2 2026, an estimated $13.7M.
Medline Inc made up 0.47% of Winton Group's portfolio in Q2 2026, its #40 holding.
Winton Group first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
239 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.